Study Indicates That ChromeMate® Favorably Influences Genes That Promote Muscle Development, Burning of Brown Fat

Study Indicates That ChromeMate® Favorably Influences Genes That Promote Muscle Development, Burning of Brown Fat Results of a new mouse study, published in Physiology Genomics, indicate that ChromeMate positively influenced the expression of numerous genes involved in fat metabolism and muscle development.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales SourceOne ActivAli(TM) Tongkat Ali Study Demonstrates Significant Benefits For Athletes and Dieters Research presented recently at the 3rd annual International Society of Sports Nutrition Conference indicates that ActivAli(TM) safely enhanced testosterone while simultaneously lowering cortisol levels. Neptune Releases Final ADHD Study Results Showing Significant Beneficial Effects of NKO(TM) Non-randomized Phase I open label clinical study on 30 patients, entitled "Evaluation of the effect of Neptune Krill Oil (NKO(TM)) on Attention Deficit Hyperactivity Disorder (ADHD)", evaluated the effect of NKO(TM) on adult ADHD as measured by Barkley's Executive Function score of behaviour inhibition, daily functional capacity and social behaviour. Neptune Releases Final ADHD Study Results Showing Significant Beneficial Effects of NKO(TM) Non-randomized Phase I open label clinical study on 30 patients, entitled "Evaluation of the effect of Neptune Krill Oil (NKO(TM)) on Attention Deficit Hyperactivity Disorder (ADHD)", evaluated the effect of NKO(TM) on adult ADHD as measured by Barkley's Executive Function score of behaviour inhibition, daily functional capacity and social behaviour. Neptune Releases Final ADHD Study Results Showing Significant Beneficial Effects of NKO(TM) Non-randomized Phase I open label clinical study on 30 patients, entitled "Evaluation of the effect of Neptune Krill Oil (NKO(TM)) on Attention Deficit Hyperactivity Disorder (ADHD)", evaluated the effect of NKO(TM) on adult ADHD as measured by Barkley's Executive Function score of behaviour inhibition, daily functional capacity and social behaviour. New Published Research Affirms the Benefits of Diachrome(R) for Improving Blood Sugar in People with Type 2 Diabetes results of a recent placebo controlled, double-blind, randomized, single center study, published in the December issue of Diabetes Technology and Therapeutics, indicate that Diachrome(R), a patented combination of chromium picolinate and biotin, safely improves blood glucose levels and cholesterol metabolism in people with type 2 diabetes. New Published Research Affirms the Benefits of Diachrome(R) for Improving Blood Sugar in People with Type 2 Diabetes results of a recent placebo controlled, double-blind, randomized, single center study, published in the December issue of Diabetes Technology and Therapeutics, indicate that Diachrome(R), a patented combination of chromium picolinate and biotin, safely improves blood glucose levels and cholesterol metabolism in people with type 2 diabetes. New Published Research Affirms the Benefits of Diachrome(R) for Improving Blood Sugar in People with Type 2 Diabetes results of a recent placebo controlled, double-blind, randomized, single center study, published in the December issue of Diabetes Technology and Therapeutics, indicate that Diachrome(R), a patented combination of chromium picolinate and biotin, safely improves blood glucose levels and cholesterol metabolism in people with type 2 diabetes. New Published Research Affirms the Benefits of Diachrome(R) for Improving Blood Sugar in People with Type 2 Diabetes results of a recent placebo controlled, double-blind, randomized, single center study, published in the December issue of Diabetes Technology and Therapeutics, indicate that Diachrome(R), a patented combination of chromium picolinate and biotin, safely improves blood glucose levels and cholesterol metabolism in people with type 2 diabetes. New Published Research Affirms the Benefits of Diachrome(R) for Improving Blood Sugar in People with Type 2 Diabetes results of a recent placebo controlled, double-blind, randomized, single center study, published in the December issue of Diabetes Technology and Therapeutics, indicate that Diachrome(R), a patented combination of chromium picolinate and biotin, safely improves blood glucose levels and cholesterol metabolism in people with type 2 diabetes. Studies Continue to Show Promising Power of Berry Antioxidants Antioxidants have been the subject of intense research since the 19th century. However, the motivation behind studies of antioxidants is much different today compared to 100 years ago. Studies Continue to Show Promising Power of Berry Antioxidants Antioxidants have been the subject of intense research since the 19th century. However, the motivation behind studies of antioxidants is much different today compared to 100 years ago. Studies Continue to Show Promising Power of Berry Antioxidants Antioxidants have been the subject of intense research since the 19th century. However, the motivation behind studies of antioxidants is much different today compared to 100 years ago. Studies Continue to Show Promising Power of Berry Antioxidants Antioxidants have been the subject of intense research since the 19th century. However, the motivation behind studies of antioxidants is much different today compared to 100 years ago. Study: Lactobacillus Reuteri Against Colic A clinical study of the effect of Lactobacillus reuteri on colic, which was recently in the scientific journal Pediatrics, compared BioGaia probiotic oil drops containing Lactobacillus reuteri and the medicine that is normally used against colic. Study: Lactobacillus Reuteri Against Colic A clinical study of the effect of Lactobacillus reuteri on colic, which was recently in the scientific journal Pediatrics, compared BioGaia probiotic oil drops containing Lactobacillus reuteri and the medicine that is normally used against colic. Neptune Initiates Risk–Benefit Analysis Study for NKO™ in the Treatment of Dyslipidemia Company announces the initiation of a population-based risk–benefit analysis study for Neptune Krill Oil (NKO(TM)) in the management of dyslipidemia. Neptune Initiates Risk–Benefit Analysis Study for NKO™ in the Treatment of Dyslipidemia Company announces the initiation of a population-based risk–benefit analysis study for Neptune Krill Oil (NKO(TM)) in the management of dyslipidemia. Study shows POMELLA® Extract increases plasma antioxidant capacity in humans A recent clinical pharmacokinetic trial ( Journal of Agricultural and Food Chemistry. 2006 Nov 15;54(23):8956-61) has demonstrated that POMELLA® Extract standardized to the primary pomegranate ellagitannins punicalagins can deliver absorbable ellagic acid (EA) and other antioxidant metabolites, and cause antioxidant effects measured by plasma ORAC. Study shows POMELLA® Extract increases plasma antioxidant capacity in humans A recent clinical pharmacokinetic trial ( Journal of Agricultural and Food Chemistry. 2006 Nov 15;54(23):8956-61) has demonstrated that POMELLA® Extract standardized to the primary pomegranate ellagitannins punicalagins can deliver absorbable ellagic acid (EA) and other antioxidant metabolites, and cause antioxidant effects measured by plasma ORAC. Study shows POMELLA® Extract increases plasma antioxidant capacity in humans A recent clinical pharmacokinetic trial ( Journal of Agricultural and Food Chemistry. 2006 Nov 15;54(23):8956-61) has demonstrated that POMELLA® Extract standardized to the primary pomegranate ellagitannins punicalagins can deliver absorbable ellagic acid (EA) and other antioxidant metabolites, and cause antioxidant effects measured by plasma ORAC. Enzyme Supplements: New Frontier of Healthcare? As alternative treatments become mainstream, doctors discover enzyme supplements may offer relief from indigestion, inflammation, and more Enzyme Supplements: New Frontier of Healthcare? As alternative treatments become mainstream, doctors discover enzyme supplements may offer relief from indigestion, inflammation, and more Nutri Pharma research on the detrimental effects of UHT processing of Soy protein published(1) A recently published placebo-controlled, randomised, double-blind clinical study over 4 weeks (80 persons) carried out in conjunction with the Karolinska Institute in Stockholm and the University of Potsdam has found that soy protein products which have been UHT treated lose their ability to reduce serum cholesterol, and can significantly increase the levels of harmful LDL cholesterol. Nutri Pharma research on the detrimental effects of UHT processing of Soy protein published(1) A recently published placebo-controlled, randomised, double-blind clinical study over 4 weeks (80 persons) carried out in conjunction with the Karolinska Institute in Stockholm and the University of Potsdam has found that soy protein products which have been UHT treated lose their ability to reduce serum cholesterol, and can significantly increase the levels of harmful LDL cholesterol. Nutri Pharma research on the detrimental effects of UHT processing of Soy protein published(1) A recently published placebo-controlled, randomised, double-blind clinical study over 4 weeks (80 persons) carried out in conjunction with the Karolinska Institute in Stockholm and the University of Potsdam has found that soy protein products which have been UHT treated lose their ability to reduce serum cholesterol, and can significantly increase the levels of harmful LDL cholesterol. Nutri Pharma research on the detrimental effects of UHT processing of Soy protein published(1) A recently published placebo-controlled, randomised, double-blind clinical study over 4 weeks (80 persons) carried out in conjunction with the Karolinska Institute in Stockholm and the University of Potsdam has found that soy protein products which have been UHT treated lose their ability to reduce serum cholesterol, and can significantly increase the levels of harmful LDL cholesterol. Nutri Pharma research on the detrimental effects of UHT processing of Soy protein published(1) A recently published placebo-controlled, randomised, double-blind clinical study over 4 weeks (80 persons) carried out in conjunction with the Karolinska Institute in Stockholm and the University of Potsdam has found that soy protein products which have been UHT treated lose their ability to reduce serum cholesterol, and can significantly increase the levels of harmful LDL cholesterol. Inconsistencies In National Dietary Guidelines For Cholesterol Examined A new study from the Life Sciences Research Office, Inc., (LSRO) explores why various nations’ dietary guidelines differ in their treatment of cholesterol. Inconsistencies In National Dietary Guidelines For Cholesterol Examined A new study from the Life Sciences Research Office, Inc., (LSRO) explores why various nations’ dietary guidelines differ in their treatment of cholesterol. Inconsistencies In National Dietary Guidelines For Cholesterol Examined A new study from the Life Sciences Research Office, Inc., (LSRO) explores why various nations’ dietary guidelines differ in their treatment of cholesterol. Inconsistencies In National Dietary Guidelines For Cholesterol Examined A new study from the Life Sciences Research Office, Inc., (LSRO) explores why various nations’ dietary guidelines differ in their treatment of cholesterol. Inconsistencies In National Dietary Guidelines For Cholesterol Examined A new study from the Life Sciences Research Office, Inc., (LSRO) explores why various nations’ dietary guidelines differ in their treatment of cholesterol. New Study Shows Walnuts Improve Bone Health In a study published in the journal Nutrition, research suggests walnuts, rich in alpha-linolenic acid (ALA), an essential omega-3 fatty acid, are beneficial to the skeletal system by decreasing the breakdown of bone. New Study Shows Walnuts Improve Bone Health In a study published in the journal Nutrition, research suggests walnuts, rich in alpha-linolenic acid (ALA), an essential omega-3 fatty acid, are beneficial to the skeletal system by decreasing the breakdown of bone. New Study Shows Walnuts Improve Bone Health In a study published in the journal Nutrition, research suggests walnuts, rich in alpha-linolenic acid (ALA), an essential omega-3 fatty acid, are beneficial to the skeletal system by decreasing the breakdown of bone. Folic Acid Supplementation May Improve Cognitive Performance In the Folic Acid and Carotid Intima-media Thickness (FACIT) trial, Jane Durga (Wageningen University and Wageningen Centre for Food Sciences, Netherlands) and colleagues randomly assigned 818 participants 800 g daily oral folic acid supplementation or placebo for 3 years. They found that cognitive functions such as memory and information processing speed improved in adults given folic acid compared with placebo. Folic Acid Supplementation May Improve Cognitive Performance In the Folic Acid and Carotid Intima-media Thickness (FACIT) trial, Jane Durga (Wageningen University and Wageningen Centre for Food Sciences, Netherlands) and colleagues randomly assigned 818 participants 800 g daily oral folic acid supplementation or placebo for 3 years. They found that cognitive functions such as memory and information processing speed improved in adults given folic acid compared with placebo. Folic Acid Supplementation May Improve Cognitive Performance In the Folic Acid and Carotid Intima-media Thickness (FACIT) trial, Jane Durga (Wageningen University and Wageningen Centre for Food Sciences, Netherlands) and colleagues randomly assigned 818 participants 800 g daily oral folic acid supplementation or placebo for 3 years. They found that cognitive functions such as memory and information processing speed improved in adults given folic acid compared with placebo. Folic Acid Supplementation May Improve Cognitive Performance In the Folic Acid and Carotid Intima-media Thickness (FACIT) trial, Jane Durga (Wageningen University and Wageningen Centre for Food Sciences, Netherlands) and colleagues randomly assigned 818 participants 800 g daily oral folic acid supplementation or placebo for 3 years. They found that cognitive functions such as memory and information processing speed improved in adults given folic acid compared with placebo. Folic Acid Supplementation May Improve Cognitive Performance In the Folic Acid and Carotid Intima-media Thickness (FACIT) trial, Jane Durga (Wageningen University and Wageningen Centre for Food Sciences, Netherlands) and colleagues randomly assigned 818 participants 800 g daily oral folic acid supplementation or placebo for 3 years. They found that cognitive functions such as memory and information processing speed improved in adults given folic acid compared with placebo. Health Enhancement Products Announces Final Results of Clinical Trials of ProAlgaZyme Company announces the final results of two clinical trials involving its ProAlgaZyme product (PAZ) conducted by the Laboratory of Nutrition and Nutritional Biochemistry at the University of Yaounde, Cameroon. One study involved participants with Metabolic Syndrome, a condition typified by metabolic and lipid imbalances where positive results were seen in cholesterol levels, cholesterol ratios, and C-reactive protein levels, while the other involved patients infected with HIV virus, where high dose groups showed positive results including reduction in viral load and increase in levels of CD4+ cells. Health Enhancement Products Announces Final Results of Clinical Trials of ProAlgaZyme Company announces the final results of two clinical trials involving its ProAlgaZyme product (PAZ) conducted by the Laboratory of Nutrition and Nutritional Biochemistry at the University of Yaounde, Cameroon. One study involved participants with Metabolic Syndrome, a condition typified by metabolic and lipid imbalances where positive results were seen in cholesterol levels, cholesterol ratios, and C-reactive protein levels, while the other involved patients infected with HIV virus, where high dose groups showed positive results including reduction in viral load and increase in levels of CD4+ cells. Scientific Experts Call For Increased Vitamin D UL Four nutrition experts, including two Council for Responsible Nutrition (CRN) scientists and two of the world’s pre-eminent vitamin D researchers, are urging the Food and Nutrition Board (FNB) to raise the vitamin D Tolerable Upper Intake Level (UL) five-fold, based on a safety evaluation of the latest scientific research that shows this vitamin to be safe at intake levels much higher than its current UL. Scientific Experts Call For Increased Vitamin D UL Four nutrition experts, including two Council for Responsible Nutrition (CRN) scientists and two of the world’s pre-eminent vitamin D researchers, are urging the Food and Nutrition Board (FNB) to raise the vitamin D Tolerable Upper Intake Level (UL) five-fold, based on a safety evaluation of the latest scientific research that shows this vitamin to be safe at intake levels much higher than its current UL. Study: Selenomax(R) Suppresses Progression of the Human Immunodeficiency Virus (HIV-1) According to Results Published in Archives of Internal Medicine Results of a five-year, double-blind, placebo-controlled study conducted by researchers at the University of Miami and published in the January 22 issue of the American Medical Association's Archives of Internal Medicine indicate that daily supplementation with Selenomax(R), Nutrition 21's high selenium yeast product, suppressed progression of the human immunodeficiency virus (HIV-1) and improved immune cell CD4 counts in HIV-1 seropositive men and women. Study: Selenomax(R) Suppresses Progression of the Human Immunodeficiency Virus (HIV-1) According to Results Published in Archives of Internal Medicine Results of a five-year, double-blind, placebo-controlled study conducted by researchers at the University of Miami and published in the January 22 issue of the American Medical Association's Archives of Internal Medicine indicate that daily supplementation with Selenomax(R), Nutrition 21's high selenium yeast product, suppressed progression of the human immunodeficiency virus (HIV-1) and improved immune cell CD4 counts in HIV-1 seropositive men and women. Study: Selenomax(R) Suppresses Progression of the Human Immunodeficiency Virus (HIV-1) According to Results Published in Archives of Internal Medicine Results of a five-year, double-blind, placebo-controlled study conducted by researchers at the University of Miami and published in the January 22 issue of the American Medical Association's Archives of Internal Medicine indicate that daily supplementation with Selenomax(R), Nutrition 21's high selenium yeast product, suppressed progression of the human immunodeficiency virus (HIV-1) and improved immune cell CD4 counts in HIV-1 seropositive men and women. Study: Selenomax(R) Suppresses Progression of the Human Immunodeficiency Virus (HIV-1) According to Results Published in Archives of Internal Medicine Results of a five-year, double-blind, placebo-controlled study conducted by researchers at the University of Miami and published in the January 22 issue of the American Medical Association's Archives of Internal Medicine indicate that daily supplementation with Selenomax(R), Nutrition 21's high selenium yeast product, suppressed progression of the human immunodeficiency virus (HIV-1) and improved immune cell CD4 counts in HIV-1 seropositive men and women. Study: Selenomax(R) Suppresses Progression of the Human Immunodeficiency Virus (HIV-1) According to Results Published in Archives of Internal Medicine Results of a five-year, double-blind, placebo-controlled study conducted by researchers at the University of Miami and published in the January 22 issue of the American Medical Association's Archives of Internal Medicine indicate that daily supplementation with Selenomax(R), Nutrition 21's high selenium yeast product, suppressed progression of the human immunodeficiency virus (HIV-1) and improved immune cell CD4 counts in HIV-1 seropositive men and women. Folic Acid May Prevent Cleft Lip and Palate Researchers at the National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health, found that 0.4 milligrams (mg) a day of folic acid reduced by one third the baby’s risk of isolated cleft lip (with or without cleft palate). Folic Acid May Prevent Cleft Lip and Palate Researchers at the National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health, found that 0.4 milligrams (mg) a day of folic acid reduced by one third the baby’s risk of isolated cleft lip (with or without cleft palate). Folic Acid May Prevent Cleft Lip and Palate Researchers at the National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health, found that 0.4 milligrams (mg) a day of folic acid reduced by one third the baby’s risk of isolated cleft lip (with or without cleft palate). Folic Acid May Prevent Cleft Lip and Palate Researchers at the National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health, found that 0.4 milligrams (mg) a day of folic acid reduced by one third the baby’s risk of isolated cleft lip (with or without cleft palate). Folic Acid May Prevent Cleft Lip and Palate Researchers at the National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health, found that 0.4 milligrams (mg) a day of folic acid reduced by one third the baby’s risk of isolated cleft lip (with or without cleft palate). Latest Study Compares Arnica to Ibuprofen A randomized, double-blind study comparing Arnica Gel to 5% Ibuprofen Gel, to be published in Rheumatology International, evaluated the Arnica Gel to be more effective by the patients and their doctors Latest Study Compares Arnica to Ibuprofen A randomized, double-blind study comparing Arnica Gel to 5% Ibuprofen Gel, to be published in Rheumatology International, evaluated the Arnica Gel to be more effective by the patients and their doctors Omega-3 Fatty Acids May Alleviate Symptoms of Bechterews Disease Results from a clinical study of patients living north of the polar circle in Sweden and suffering from Ankylosing Spondolitis, or Bechterews disease, indicate that treatment with marine- based Omega-3 fatty acids may provide relief of symptoms in Bechterew patients and possibly also delay disease progression. Omega-3 Fatty Acids May Alleviate Symptoms of Bechterews Disease Results from a clinical study of patients living north of the polar circle in Sweden and suffering from Ankylosing Spondolitis, or Bechterews disease, indicate that treatment with marine- based Omega-3 fatty acids may provide relief of symptoms in Bechterew patients and possibly also delay disease progression. Omega-3 Fatty Acids May Alleviate Symptoms of Bechterews Disease Results from a clinical study of patients living north of the polar circle in Sweden and suffering from Ankylosing Spondolitis, or Bechterews disease, indicate that treatment with marine- based Omega-3 fatty acids may provide relief of symptoms in Bechterew patients and possibly also delay disease progression. Omega-3 Fatty Acids May Alleviate Symptoms of Bechterews Disease Results from a clinical study of patients living north of the polar circle in Sweden and suffering from Ankylosing Spondolitis, or Bechterews disease, indicate that treatment with marine- based Omega-3 fatty acids may provide relief of symptoms in Bechterew patients and possibly also delay disease progression. Omega-3 Fatty Acids May Alleviate Symptoms of Bechterews Disease Results from a clinical study of patients living north of the polar circle in Sweden and suffering from Ankylosing Spondolitis, or Bechterews disease, indicate that treatment with marine- based Omega-3 fatty acids may provide relief of symptoms in Bechterew patients and possibly also delay disease progression. Review Indicates That Chromium Picolinate Shows Clinical Benefits in Diabetes Management A review of 15 clinical studies of people with diabetes, published in Diabetes Technology & Therapeutics, confirms that chromium picolinate is effective in improving glycemic control and normalizing lipid levels in people with type 2 diabetes. Review Indicates That Chromium Picolinate Shows Clinical Benefits in Diabetes Management A review of 15 clinical studies of people with diabetes, published in Diabetes Technology & Therapeutics, confirms that chromium picolinate is effective in improving glycemic control and normalizing lipid levels in people with type 2 diabetes. Review Indicates That Chromium Picolinate Shows Clinical Benefits in Diabetes Management A review of 15 clinical studies of people with diabetes, published in Diabetes Technology & Therapeutics, confirms that chromium picolinate is effective in improving glycemic control and normalizing lipid levels in people with type 2 diabetes. Review Indicates That Chromium Picolinate Shows Clinical Benefits in Diabetes Management A review of 15 clinical studies of people with diabetes, published in Diabetes Technology & Therapeutics, confirms that chromium picolinate is effective in improving glycemic control and normalizing lipid levels in people with type 2 diabetes. Review Indicates That Chromium Picolinate Shows Clinical Benefits in Diabetes Management A review of 15 clinical studies of people with diabetes, published in Diabetes Technology & Therapeutics, confirms that chromium picolinate is effective in improving glycemic control and normalizing lipid levels in people with type 2 diabetes. Study Indicates GliSODin® Shown to Inhibit Surgery-Related Cellular DNA Damage P.L. Thomas, in association with Isocell, Paris, France, announced the results of a new study, indicating that GliSODin, supplementation prior to an invasive surgical procedure, was shown to significantly inhibit several measures of cellular damage, including DNA damage and protection of spinal cord tissues, without negative effects or impairing organ function. Study Indicates GliSODin® Shown to Inhibit Surgery-Related Cellular DNA Damage P.L. Thomas, in association with Isocell, Paris, France, announced the results of a new study, indicating that GliSODin, supplementation prior to an invasive surgical procedure, was shown to significantly inhibit several measures of cellular damage, including DNA damage and protection of spinal cord tissues, without negative effects or impairing organ function. Study Indicates GliSODin® Shown to Inhibit Surgery-Related Cellular DNA Damage P.L. Thomas, in association with Isocell, Paris, France, announced the results of a new study, indicating that GliSODin, supplementation prior to an invasive surgical procedure, was shown to significantly inhibit several measures of cellular damage, including DNA damage and protection of spinal cord tissues, without negative effects or impairing organ function. Study Indicates GliSODin® Shown to Inhibit Surgery-Related Cellular DNA Damage P.L. Thomas, in association with Isocell, Paris, France, announced the results of a new study, indicating that GliSODin, supplementation prior to an invasive surgical procedure, was shown to significantly inhibit several measures of cellular damage, including DNA damage and protection of spinal cord tissues, without negative effects or impairing organ function. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	BENICIA, Calif., January 16, 2007 – In a promising new study, researchers at Ohio State University Medical Center have shown that ChromeMate® affects fat metabolism and muscle activity at the genetic level. ChromeMate, produced by InterHealth Nutraceuticals, is an oxygen-coordinated niacin-bound form of supplemental chromium that has previously been shown to promote healthy glucose metabolism and lipid profiles, as well as lean body mass. It has been affirmed GRAS (Generally Recognized as Safe) for use in functional beverages. In this new study, researchers looked at the effect that ChromeMate might have on risk factors involved in Metabolic Syndrome, a cluster of symptoms that can include abdominal obesity, inefficient insulin action, high triglyceride and LDL (“bad”) cholesterol levels, and low levels of HDL (“good”) cholesterol. Metabolic Syndrome can increase the risk of developing cardiovascular disease and type-2 diabetes. The results of the new study showed that ChromeMate positively influenced the expression of numerous genes involved in fat metabolism and muscle development. The study, recently published in Physiology Genomics, was conducted with Leprdb mice, which are born obese and diabetic and are a useful model for studying Metabolic Syndrome. The Leprdb mice typically suffer from abnormally high blood glucose and lipid profiles beginning at 30 days of life. Researchers investigated the effects of ChromeMate versus placebo on the subcutaneous fat tissue (the fat tissue that lies under the second layer of the skin) of the animals by means of Gene Microarray Analysis, using more than 45,000 sets of mouse genome. ChromeMate up-regulated (activated) the expression of four muscle-specific genes within the subcutaneous fat. These genes provide the signal for pre-adipocytes (fat precursor cells) to produce muscle instead of fat cells. These findings corroborate earlier studies showing that ChromeMate enhances the production of lean body mass. ChromeMate down-regulated (de-activated) genes that encode (possess genetic information) for CIDEA and UCP1, which are key components in brown fat tissue thermogenesis, or the burning of fat for heat production. CIDEA is considered a “candidate” gene for obesity; mice that do not possess this gene are resistant to diet-induced obesity and diabetes. ChromeMate also down-regulated TTP, a gene that provides antioxidant support to all tissues for survival, in the subcutaneous fat. Therefore, ChromeMate stops antioxidant support to the subcutaneous fat tissues and ultimately kills the fat cells. “We were very pleased with these findings,” said Debasis Bagchi, Ph.D., F.A.C.N., Senior Vice President of Research and Development for InterHealth. “The down-regulation of CIDEA and UCP1 is particularly heartening, because of their specific role related to obesity and because brown fat is the most difficult type of fat for people to lose. These results tell us that supplementation may in fact help individuals who are predisposed to having a problem losing brown fat tissue,” Dr. Bagchi added. Dr. Bagchi also pointed out that ChromeMate influenced only a small select percentage of the genes screened, signifying that the supplement’s effect was limited to genes that it could positively impact and did not affect genes that could alter normal body functions or be considered indicators of toxicity in the body. Prior to conducting the gene expression tests, researchers investigated the effects of ChromeMate supplementation versus placebo on blood lipid and glucose profiles in the Leprdb mice. The findings corroborated previous studies showing that ChromeMate improved blood lipids and increased the clearance of glucose from the bloodstream. ChromeMate significantly lowered total cholesterol, LDL cholesterol and triglyceride levels, and increased the level of HDL cholesterol. In addition, blood glucose cleared more rapidly in response to an oral glucose tolerance test. # # # About InterHealth Nutraceuticals, Inc. InterHealth Nutraceuticals researches, develops, markets and distributes specialty nutritional ingredients, which are sold worldwide to manufacturers of dietary supplements and nutraceutical food and beverage products. The company’s products include Super CitriMax®, ChromeMate®, Aller-7®, OptiBerry ®, UC-II®, L-OptiZinc®, Protykin® and ZMA®. For more information about InterHealth and its products, call 1-800-783-4636 or 1-707-751-2800 (outside U.S.) or visit the website at www.interhealthusa.com.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software